LINC01138

Across TCGA pan-cancer cohorts, LINC01138 Mutation is linked to patient survival in 4 of 34 cancer types, making it a survival-associated LINC01138 data layer compared with 21 for mass-spec protein.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher LINC01138 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated LINC01138 expression acts as an unfavorable survival marker, although some lineages such as SARC show a favorable association.

HNSC, COAD, and UCEC are the cancer types where LINC01138 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	OS	Median	All	0.087	0.768	<.001	48	view →
COAD	OS	Median	All	0.168	0.806	.002	12	view →
UCEC	OS	Median	IV	0.231	0.592	.036	6	view →
SARC	DFS	Median	All	1.000	0.329	.047	1	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

LINC01138–HNSC (OS)

Open the HNSC breakdown →